Efficacy of cabergoline therapy in patients with non-functioning pituitary adenomas: A single center clinical experience

OBJECTIVE: To evaluate the response to cabergoline (CBG) treatment in patients with non-functioning pituitary adenomas (NFPA). SUBJECTS AND METHODS: Retrospective, single tertiary care center study. A total of 44 patients were treated with 3 mg/week of CBG, 32 after surgical treatment (transsphenoid...

Descripción completa

Detalles Bibliográficos
Autores principales: Vargas-Ortega, Guadalupe, González-Virla, Baldomero, Balcázar-Hernández, Lourdes, Arreola-Rosales, Rocío, Benitez-Rodríguez, Francisco Javier, Félix, Blas López, Mercado, Moisés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697635/
https://www.ncbi.nlm.nih.gov/pubmed/35758837
http://dx.doi.org/10.20945/2359-3997000000495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697635/
https://www.ncbi.nlm.nih.gov/pubmed/35758837
http://dx.doi.org/10.20945/2359-3997000000495

Ejemplares similares